Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 51.63%5.8B | 49.23%3.73B | 46.07%1.76B | 15.20%5.66B | 4.00%3.83B | 3.16%2.5B | -0.80%1.21B | 3.78%4.92B | 8.30%3.68B | 7.81%2.43B |
| Operating revenue | 51.63%5.8B | 49.23%3.73B | 46.07%1.76B | 15.20%5.66B | 4.00%3.83B | 3.16%2.5B | -0.79%1.21B | 3.78%4.92B | 8.31%3.68B | 7.83%2.43B |
| Other operating revenue | ---- | -63.96%4.36M | ---- | -72.64%17.82M | ---- | -76.58%12.1M | ---- | 49.73%65.13M | ---- | 105.56%51.66M |
| Interest income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -96.40%15.14K | -95.77%15.14K | -93.97%15.14K |
| Total operating cost | 57.08%6.83B | 61.11%4.41B | 75.39%2.17B | 39.90%6.34B | 34.72%4.35B | 30.61%2.74B | 23.56%1.24B | 16.07%4.53B | 21.74%3.23B | 11.32%2.09B |
| Operating cost | 97.54%1.75B | 106.21%1.12B | 109.85%546.63M | 43.94%1.5B | 18.10%884.26M | 13.48%545.35M | 24.28%260.49M | 3.83%1.04B | 2.92%748.73M | 0.03%480.59M |
| Operating tax surcharges | -5.06%2.85M | -14.69%1.78M | -21.29%937.32K | -36.87%4.04M | -44.98%3M | -48.78%2.08M | -54.29%1.19M | 14.86%6.4M | 17.19%5.46M | 61.14%4.07M |
| Operating expense | 105.75%2.89B | 95.57%1.83B | 92.11%868.49M | 42.23%2.3B | 16.09%1.4B | 20.99%934.44M | 15.57%452.08M | 3.41%1.62B | 13.93%1.21B | 7.01%772.35M |
| Administration expense | 6.84%931.98M | 33.04%620.18M | 93.87%309.46M | 7.32%924.02M | 41.18%872.33M | 1.00%466.17M | -29.88%159.62M | 37.08%861.02M | 72.57%617.89M | 26.28%461.54M |
| Financial expense | 18.04%45.1M | 15.54%34.6M | -2.38%15.73M | 86.79%65.11M | 58.71%38.21M | 21.14%29.95M | 3,606.51%16.11M | 237.24%34.86M | 70.86%24.07M | 357.36%24.72M |
| -Interest expense (Financial expense) | 11.01%41.88M | 14.67%30.76M | 3.08%13.47M | 47.95%63.34M | 31.39%37.73M | 53.71%26.82M | 52.88%13.07M | -3.27%42.81M | -45.18%28.72M | -33.68%17.45M |
| -Interest Income (Financial expense) | -15.91%-21.81M | -20.89%-15.65M | -14.68%-7.08M | 10.98%-27.27M | 16.22%-18.82M | 7.58%-12.95M | -9.37%-6.17M | -4.65%-30.63M | 18.45%-22.46M | -3.34%-14.01M |
| Research and development | 5.83%1.21B | 5.41%798.37M | 23.43%430.36M | 59.46%1.54B | 84.47%1.14B | 115.72%757.41M | 104.37%348.66M | 40.16%967.58M | 28.18%620.34M | 14.79%351.12M |
| Credit Impairment Loss | -2,690.58%-8.35M | -65.19%-11.92M | -72.94%-2.41M | -85.08%-29.87M | 106.11%322.34K | -30.94%-7.21M | 89.24%-1.4M | -124.53%-16.14M | -114.74%-5.27M | -115.04%-5.51M |
| Asset Impairment Loss | ---10.89M | ---9.62M | ---5.26M | -6,584.73%-320.97M | ---- | ---- | ---- | 96.64%-4.8M | ---3.96M | ---- |
| Other net revenue | 110.38%27.36M | -125.23%-422.46M | -294.04%-498.05M | -174.05%-1.14B | -358.63%-263.65M | -194.45%-187.57M | -244.59%-126.4M | 172.07%1.54B | -52.17%101.94M | -40.33%198.59M |
| Fair value change income | 130.03%81.26M | -116.68%-377.02M | -329.78%-491.35M | -164.26%-824.68M | -414.90%-270.62M | -196.50%-174M | -233.20%-114.33M | 169.30%1.28B | -51.35%85.94M | -34.57%180.3M |
| Invest income | -95.08%-35.6M | 11.66%-21.6M | 112.34%1.82M | -96.37%9.26M | -379.36%-18.25M | -301.59%-24.46M | -392.36%-14.71M | 80.96%255.27M | 131.42%6.53M | 40.07%12.13M |
| -Including: Investment income associates | -134.08%-39.97M | 69.48%-7.11M | 89.48%-1.26M | -91.18%10.68M | -51.65%-17.07M | -141.58%-23.3M | -9.14%-11.98M | 51.60%121.15M | -39.46%-11.26M | -133.99%-9.65M |
| Asset deal income | -160.58%-6.95M | -189.18%-8.05M | -358.90%-5.56M | 269.80%12.75M | 1,558.74%11.47M | 1,402.90%9.03M | 1,400.21%2.15M | 318.70%3.45M | 98.60%691.52K | 76.30%600.65K |
| Other revenue | -41.24%7.89M | -36.68%5.74M | 150.18%4.73M | -45.03%11.54M | -25.49%13.42M | -17.99%9.07M | -79.87%1.89M | -18.03%20.99M | -14.82%18.01M | -4.98%11.06M |
| Operating profit | -27.32%-996.03M | -160.27%-1.1B | -476.95%-905.78M | -194.22%-1.82B | -240.57%-782.31M | -179.55%-421.16M | -151.88%-156.99M | 37.62%1.93B | -42.13%556.51M | -24.45%529.45M |
| Add:Non operating Income | 601.59%475.37K | 676.55%424.12K | 4.47%40.4K | -90.31%88.21K | -84.26%67.76K | -87.07%54.62K | -49.58%38.67K | -11.55%910.33K | -46.20%430.35K | 48.41%422.56K |
| Less:Non operating expense | -14.33%1.85M | -0.36%1.28M | -94.53%43.41K | -93.64%3.14M | -65.04%2.16M | -69.15%1.29M | 1,119.97%794.03K | 253.80%49.37M | -32.95%6.17M | -52.79%4.17M |
| Total profit | -27.16%-997.4M | -159.71%-1.1B | -474.19%-905.78M | -196.82%-1.82B | -242.42%-784.4M | -180.35%-422.39M | -152.13%-157.75M | 35.41%1.88B | -42.22%550.76M | -24.06%525.71M |
| Less:Income tax cost | -16.93%89.07M | -34.83%50.65M | -50.52%23.59M | -63.16%127.59M | -4.16%107.23M | -8.71%77.73M | 11.66%47.68M | 125.11%346.28M | -10.65%111.88M | 103.16%85.14M |
| Net profit | -21.85%-1.09B | -129.48%-1.15B | -352.40%-929.38M | -227.01%-1.95B | -303.16%-891.62M | -213.52%-500.12M | -179.04%-205.43M | 24.23%1.53B | -47.00%438.88M | -32.26%440.57M |
| Net profit from continuing operation | -21.85%-1.09B | -129.48%-1.15B | -352.40%-929.38M | -227.01%-1.95B | -303.16%-891.62M | -213.52%-500.12M | -179.04%-205.43M | 24.23%1.53B | -47.00%438.88M | -32.26%440.57M |
| Less:Minority Profit | -58.87%-421.15M | -163.21%-292.11M | -790.05%-160.38M | -228.26%-352.24M | -339.85%-265.09M | -234.72%-110.98M | -137.65%-18.02M | 238.44%274.62M | 167.22%110.52M | 1,040.33%82.38M |
| Net profit of parent company owners | -6.19%-665.32M | -119.86%-855.55M | -310.32%-769M | -226.74%-1.59B | -290.81%-626.53M | -208.64%-389.14M | -188.38%-187.41M | 9.15%1.26B | -58.26%328.36M | -44.31%358.19M |
| Earning per share | ||||||||||
| Basic earning per share | -5.88%-0.54 | -115.63%-0.69 | -313.33%-0.62 | -223.81%-1.3 | -282.14%-0.51 | -206.67%-0.32 | -183.33%-0.15 | 8.25%1.05 | -57.58%0.28 | -44.44%0.3 |
| Diluted earning per share | -5.88%-0.54 | -115.63%-0.69 | -313.33%-0.62 | -224.51%-1.27 | -282.14%-0.51 | -210.34%-0.32 | -183.33%-0.15 | 6.25%1.02 | -57.58%0.28 | -46.30%0.29 |
| Other composite income | 190.04%86.59M | 92.81%153.37M | 678.82%264.71M | -18.06%225.25M | -128.96%-96.16M | -80.76%79.55M | -108.13%-45.73M | -69.65%274.91M | -70.78%332.05M | -23.49%413.53M |
| Other composite income of parent company owners | 253.22%111.5M | 148.06%158.59M | 387.20%199.03M | -27.04%183.37M | -126.26%-72.77M | -81.43%63.93M | 53.47%-69.3M | -59.37%251.34M | -66.16%277.15M | -12.23%344.22M |
| Other composite income of minority owners | -6.48%-24.91M | -133.42%-5.22M | 178.68%65.68M | 77.70%41.88M | -142.61%-23.39M | -77.47%15.61M | -96.69%23.57M | -91.79%23.57M | -82.72%54.91M | -53.28%69.31M |
| Total composite income | -1.22%-999.88M | -136.41%-994.28M | -164.64%-664.67M | -195.24%-1.72B | -228.13%-987.79M | -149.24%-420.57M | -130.54%-251.16M | -15.51%1.81B | -60.76%770.94M | -28.28%854.11M |
| Total composite income of parent company owners | 20.80%-553.83M | -114.31%-696.96M | -122.03%-569.97M | -193.49%-1.41B | -215.49%-699.3M | -146.30%-325.2M | -506.71%-256.71M | -14.78%1.51B | -62.29%605.51M | -32.15%702.41M |
| Total composite income of minority owners | -54.62%-446.06M | -211.77%-297.33M | -1,806.80%-94.7M | -204.08%-310.36M | -274.39%-288.49M | -162.87%-95.37M | -99.27%5.55M | -19.01%298.19M | -53.93%165.43M | -2.49%151.69M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.